|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7088 |
| (11) | Number of the document | 3129485 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15721376.0 |
| Date of filing the European patent application | 2015-04-01 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/023960 |
| Date | 2015-04-01 |
| (87) | Number | WO 2015/157070 |
| Date | 2015-10-15 |
| (30) | Number | Date | Country code |
| 201461977488 P | 2014-04-09 | US |
| (72) |
REYON, Deepak, US
MAEDER, Morgan, L., US
FRIEDLAND, Ari, E., US
WELSTEAD, G., Grant, US
BUMCROT, David, A., US
|
| (73) |
Editas Medicine, Inc.,
300 Third Street First Floor, Cambridge, MA 02142,
US
|
| (54) | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS |
| CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS |